Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:00 pm Purchase | 2021-12-31 | 13G | aTyr Pharma, Inc. ATYR | TANG CAPITAL PARTNERS LP | 1,113,453 4.000% | 50,000 (+4.70%) | Filing History |
| 2022-02-14 3:22 pm Sale | 2021-12-31 | 13G | aTyr Pharma, Inc. ATYR | Alyeska Investment Group, L.P. | 0 0.000% | -842,554 (Position Closed) | Filing History |
| 2022-02-14 1:26 pm Unchanged | 2021-12-31 | 13G | aTyr Pharma, Inc. LIFE | FEDERATED HERMES INC. FHI | 5,222,250 18.790% | 0 (Unchanged) | Filing History |
| 2022-02-09 09:09 am Purchase | 2022-02-08 | 13G | aTyr Pharma, Inc. ATYR | FMR LLC | 4,168,601 14.999% | 2,492,721 (+148.74%) | Filing History |
| 2021-10-08 2:22 pm Purchase | 2021-09-30 | 13G | aTyr Pharma, Inc. LIFE | FEDERATED HERMES INC. FHI | 5,222,250 19.860% | 3,607,250 (+223.36%) | Filing History |
| 2021-09-27 5:14 pm Purchase | 2021-09-16 | 13G | aTyr Pharma, Inc. ATYR | Venrock Healthcare Capital Partners II, L.P. | 1,815,000 6.700% | 1,815,000 (New Position) | Filing History |
| 2021-09-17 3:00 pm Purchase | 2021-09-16 | 13G | aTyr Pharma, Inc. ATYR | Ikarian Capital, LLC | 888,580 5.300% | 888,580 (New Position) | Filing History |
| 2021-09-17 12:31 pm Purchase | 2021-09-13 | 13G | aTyr Pharma, Inc. ATYR | TANG CAPITAL PARTNERS LP | 1,063,453 6.300% | 1,063,453 (New Position) | Filing History |
| 2021-07-12 12:07 pm Purchase | 2021-07-09 | 13G | aTyr Pharma, Inc. ATYR | FMR LLC | 1,675,880 10.432% | 91,196 (+5.75%) | Filing History |
| 2021-04-12 1:05 pm Purchase | 2021-04-09 | 13G | aTyr Pharma, Inc. ATYR | FMR LLC | 1,584,684 9.897% | 56,866 (+3.72%) | Filing History |
| 2021-04-09 2:14 pm Unchanged | 2021-03-31 | 13G | aTyr Pharma, Inc. LIFE | FEDERATED HERMES INC. FHI | 1,615,000 10.090% | 0 (Unchanged) | Filing History |
| 2021-02-17 06:10 am Purchase | 2021-02-12 | 13G | aTyr Pharma, Inc. LIFE | Aspire Capital Fund LLC | 1,312,537 9.150% | 1,312,537 (New Position) | Filing History |
| 2021-02-16 11:21 am Purchase | 2020-12-31 | 13G | aTyr Pharma, Inc. ATYR | Alyeska Investment Group, L.P. | 842,554 8.300% | 842,554 (New Position) | Filing History |
| 2021-02-12 7:29 pm Sale | 2020-12-31 | 13G | aTyr Pharma, Inc. LIFE | VIKING GLOBAL INVESTORS LP | 0 0.000% | -816,728 (Position Closed) | Filing History |
| 2021-02-12 3:14 pm Sale | 2020-12-31 | 13G | aTyr Pharma, Inc. ATYR | Altium Capital Management LLC | 332,258 3.200% | -142,742 (-30.05%) | Filing History |
| 2021-02-12 1:17 pm Purchase | 2020-12-31 | 13G | aTyr Pharma, Inc. LIFE | FEDERATED HERMES INC. FHI | 1,615,000 15.860% | 1,019,928 (+171.40%) | Filing History |
| 2021-02-10 6:20 pm Purchase | 2020-12-31 | 13G | aTyr Pharma, Inc. ATYR | Renaissance Technologies LLC | 319,130 3.130% | 119,210 (+59.63%) | Filing History |
| 2021-02-08 10:15 am Purchase | 2021-02-05 | 13G | aTyr Pharma, Inc. ATYR | FMR LLC | 1,527,818 14.999% | 1,036,369 (+210.88%) | Filing History |
| 2021-01-21 5:48 pm Sale | 2020-12-31 | 13G | aTyr Pharma, Inc. LIFE | Domain Partners VIII L.P. | 89,425 0.900% | -39,705 (-30.75%) | Filing History |